[1] PAZ IB, COOK N, ODOM-MARYON T, et al.Human papillomavirus(HPV) in head and neck cancer[J].Cancer, 2015, 79(3):595.
[2] BROTMAN RM, SHARDELL MD, PAWEL G, et al.Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection[J].J Infect Dis, 2014, 210(11):1723.
[3] KHAN MJ, MASSAD LS, KINNEY W, et al.A common clinical dilemma:Management of abnormal vaginal cytology and human papillomavirus test results.[J].Gynecol Oncol, 2016, 141(2):364.
[4] BUI TC, THAI TN, TRAN TH, et al.Association between vaginal douching and genital human papillomavirus infection among women in the United States[J].J Infect Dis, 2016, 214(9):1370.
[5] MANGINO G, ZANGRILLO MS, CHIANTORE MV, et al.ID:109:pro-inflammatory cytokines and chemokines in HPV-positive cancer cells[J].Cytokine, 2015, 76(1):86.
[6] PRABHAVATHY D, VIJAYALAKSHMI R, KANCHANA MP, et al.HPV16 E2 enhances the expression of NF-κB and STAT3 target genes and potentiates NF-κB activation by inflammatory mediators[J].Cell Immunol, 2014, 292(1/2):70. doi: 10.1016/j.cellimm.2014.09.005
[7] 孟龄婷, 薛艳, 岳婷, 等.HPV感染与BV、VVC、TV的相关性基于1261例妇科门诊病人的临床研究[J].中华妇产科杂志, 2016, 51(10):730. doi: 10.3760/cma.j.issn.0529-567x.2016.10.004
[8] 任忠良, 何启田, 李凯旋, 等.妇科就诊人群高危HPV感染发生率与细菌性阴道病相关性调查[J].中国地方病防治杂志, 2014, 29(s2):260.
[9] GONÇALVES B, FERREIRA C, ALVES CT, et al.Vulvovaginal candidiasis:epidemiology, microbiology and risk factors[J].Crit Rev Microbiol, 2016, 42(6):905.
[10] 杨瑾, 陈洪波, 李柱南, 等.下生殖道感染与子宫颈高危型HPV感染及转归的相关性[J].中华妇产科杂志, 2014, 49(3):2223.
[11] 夏玉洁, 王辰, 王颖梅, 等.阴道微生态异常与高危型人乳头瘤病毒感染的相关性研究[J].中国妇产科临床杂志, 2017, 18(2):131.
[12] 潘颖, 盛华芳, 康玲, 等.高危型人乳头状瘤病毒感染与阴道菌群的相关性研究[J].第三军医大学学报, 2016, 38(13):1559.
[13] 韩一栩, 刘玉珠, 陈琨.高危HPV感染老年病人的阴道菌群分布研究[J].中华医院感染学杂志, 2018, 28(5):764. doi: 10.11816/cn.ni.2017-171578
[14] 温先勇, 邓正华, 彭英, 等.西南医科大学附属医院617例人乳头瘤病毒感染者的基因型分布[J].现代预防医学, 2018, 45(7):1292.
[15] 张玲, 曲芃芃.HR-HPV持续感染宫颈局部8种细胞因子变化的研究[J].中国妇产科临床杂志, 2018, 19(1):6.
[16] 洪慧, 王鹤.HPV16、58型感染导致宫颈微环境中免疫因子变化及宫颈细胞中病毒整合的初步研究[J].中国免疫学杂志, 2014, 30(10):1378.